{"title":"腹泻的肠道疾病:FODMAPS治疗?","authors":"Pascal Crenn","doi":"10.1097/MCO.0000000000001141","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>To examine in the light of recent data whether diets low in FODMAPs (a now classic exclusion diet for treatment for IBS: irritable bowel syndrome) have shown interest/efficacy in diseases of the digestive tract (beyond IBS) manifesting as diarrhea.</p><p><strong>Recent findings: </strong>Very little good quality data or publications are available in recent medical literature. It is therefore difficult to estimate that the low FODMAP diet can be considered with a good level of confidence outside of IBS except in borderline symptomatic forms or with associated pathophysiology (e.g. IBD: inflammatory bowel disease).</p><p><strong>Summary: </strong>There is a lack of quality data on the benefits, safety and value of LFD, outside of IBS. This is particularly the case in the majority of organic digestive diseases, notably with diarrhea, unless accompanied by dysregulation of the intestine-brain axis (and so with IBS symptoms), for example in post-inflammatory situations. When effective, which is currently highly unpredictable, the mechanism of action remains poorly understood.</p>","PeriodicalId":10962,"journal":{"name":"Current Opinion in Clinical Nutrition and Metabolic Care","volume":" ","pages":"422-426"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The sick gut with diarrhea: FODMAPS for treatment?\",\"authors\":\"Pascal Crenn\",\"doi\":\"10.1097/MCO.0000000000001141\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>To examine in the light of recent data whether diets low in FODMAPs (a now classic exclusion diet for treatment for IBS: irritable bowel syndrome) have shown interest/efficacy in diseases of the digestive tract (beyond IBS) manifesting as diarrhea.</p><p><strong>Recent findings: </strong>Very little good quality data or publications are available in recent medical literature. It is therefore difficult to estimate that the low FODMAP diet can be considered with a good level of confidence outside of IBS except in borderline symptomatic forms or with associated pathophysiology (e.g. IBD: inflammatory bowel disease).</p><p><strong>Summary: </strong>There is a lack of quality data on the benefits, safety and value of LFD, outside of IBS. This is particularly the case in the majority of organic digestive diseases, notably with diarrhea, unless accompanied by dysregulation of the intestine-brain axis (and so with IBS symptoms), for example in post-inflammatory situations. When effective, which is currently highly unpredictable, the mechanism of action remains poorly understood.</p>\",\"PeriodicalId\":10962,\"journal\":{\"name\":\"Current Opinion in Clinical Nutrition and Metabolic Care\",\"volume\":\" \",\"pages\":\"422-426\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Opinion in Clinical Nutrition and Metabolic Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MCO.0000000000001141\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Clinical Nutrition and Metabolic Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MCO.0000000000001141","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The sick gut with diarrhea: FODMAPS for treatment?
Purpose of review: To examine in the light of recent data whether diets low in FODMAPs (a now classic exclusion diet for treatment for IBS: irritable bowel syndrome) have shown interest/efficacy in diseases of the digestive tract (beyond IBS) manifesting as diarrhea.
Recent findings: Very little good quality data or publications are available in recent medical literature. It is therefore difficult to estimate that the low FODMAP diet can be considered with a good level of confidence outside of IBS except in borderline symptomatic forms or with associated pathophysiology (e.g. IBD: inflammatory bowel disease).
Summary: There is a lack of quality data on the benefits, safety and value of LFD, outside of IBS. This is particularly the case in the majority of organic digestive diseases, notably with diarrhea, unless accompanied by dysregulation of the intestine-brain axis (and so with IBS symptoms), for example in post-inflammatory situations. When effective, which is currently highly unpredictable, the mechanism of action remains poorly understood.
期刊介绍:
A high impact review journal which boasts an international readership, Current Opinion in Clinical Nutrition and Metabolic Care offers a broad-based perspective on the most recent and exciting developments within the field of clinical nutrition and metabolic care. Published bimonthly, each issue features insightful editorials and high quality invited reviews covering two or three key disciplines which include protein, amino acid metabolism and therapy, lipid metabolism and therapy, nutrition and the intensive care unit and carbohydrates. Each discipline introduces world renowned guest editors to ensure the journal is at the forefront of knowledge development and delivers balanced, expert assessments of advances from the previous year.